203 related articles for article (PubMed ID: 31589480)
21. A mouse model for polycystic kidney disease through a somatic in-frame deletion in the 5' end of Pkd1.
Starremans PG; Li X; Finnerty PE; Guo L; Takakura A; Neilson EG; Zhou J
Kidney Int; 2008 Jun; 73(12):1394-405. PubMed ID: 18385665
[TBL] [Abstract][Full Text] [Related]
22. Pkd1 and Nek8 mutations affect cell-cell adhesion and cilia in cysts formed in kidney organ cultures.
Natoli TA; Gareski TC; Dackowski WR; Smith L; Bukanov NO; Russo RJ; Husson H; Matthews D; Piepenhagen P; Ibraghimov-Beskrovnaya O
Am J Physiol Renal Physiol; 2008 Jan; 294(1):F73-83. PubMed ID: 17928412
[TBL] [Abstract][Full Text] [Related]
23. Differential expression of Cux-1 and p21 in polycystic kidneys from Pkd1 null and cpk mice.
Sharma M; Brantley JG; Alcalay NI; Zhou J; Heystek E; Maser RL; Vanden Heuvel GB
Kidney Int; 2005 Feb; 67(2):432-42. PubMed ID: 15673290
[TBL] [Abstract][Full Text] [Related]
24. Prothymosin alpha.
Segade F; Gómez-Márquez J
Int J Biochem Cell Biol; 1999 Nov; 31(11):1243-8. PubMed ID: 10605816
[TBL] [Abstract][Full Text] [Related]
25. Toxic tubular injury in kidneys from Pkd1-deletion mice accelerates cystogenesis accompanied by dysregulated planar cell polarity and canonical Wnt signaling pathways.
Happé H; Leonhard WN; van der Wal A; van de Water B; Lantinga-van Leeuwen IS; Breuning MH; de Heer E; Peters DJ
Hum Mol Genet; 2009 Jul; 18(14):2532-42. PubMed ID: 19401297
[TBL] [Abstract][Full Text] [Related]
26. Steviol slows renal cyst growth by reducing AQP2 expression and promoting AQP2 degradation.
Noitem R; Yuajit C; Soodvilai S; Muanprasat C; Chatsudthipong V
Biomed Pharmacother; 2018 May; 101():754-762. PubMed ID: 29524884
[TBL] [Abstract][Full Text] [Related]
27. Autocrine IL-10 activation of the STAT3 pathway is required for pathological macrophage differentiation in polycystic kidney disease.
Peda JD; Salah SM; Wallace DP; Fields PE; Grantham CJ; Fields TA; Swenson-Fields KI
Dis Model Mech; 2016 Sep; 9(9):1051-61. PubMed ID: 27491076
[TBL] [Abstract][Full Text] [Related]
28. Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease.
Lantinga-van Leeuwen IS; Dauwerse JG; Baelde HJ; Leonhard WN; van de Wal A; Ward CJ; Verbeek S; Deruiter MC; Breuning MH; de Heer E; Peters DJ
Hum Mol Genet; 2004 Dec; 13(24):3069-77. PubMed ID: 15496422
[TBL] [Abstract][Full Text] [Related]
29. A chalcone derivative retards renal cyst enlargement by inhibiting fluid secretion and cell proliferation in an in vitro model of polycystic kidney disease.
Veeraphan P; Chavasiri W; Muanprasat C; Chatsudthipong V; Yuajit C
Clin Exp Nephrol; 2021 Sep; 25(9):944-952. PubMed ID: 34057612
[TBL] [Abstract][Full Text] [Related]
30. Rapamycin ameliorates PKD resulting from conditional inactivation of Pkd1.
Shillingford JM; Piontek KB; Germino GG; Weimbs T
J Am Soc Nephrol; 2010 Mar; 21(3):489-97. PubMed ID: 20075061
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus nuclear antigen 3C and prothymosin alpha interact with the p300 transcriptional coactivator at the CH1 and CH3/HAT domains and cooperate in regulation of transcription and histone acetylation.
Subramanian C; Hasan S; Rowe M; Hottiger M; Orre R; Robertson ES
J Virol; 2002 May; 76(10):4699-708. PubMed ID: 11967287
[TBL] [Abstract][Full Text] [Related]
32. Pannexin-1 mediates fluid shear stress-sensitive purinergic signaling and cyst growth in polycystic kidney disease.
Verschuren EHJ; Rigalli JP; Castenmiller C; Rohrbach MU; Bindels RJM; Peters DJM; Arjona FJ; Hoenderop JGJ
FASEB J; 2020 May; 34(5):6382-6398. PubMed ID: 32159259
[TBL] [Abstract][Full Text] [Related]
33. Quercetin inhibits renal cyst growth in vitro and via parenteral injection in a polycystic kidney disease mouse model.
Zhu Y; Teng T; Wang H; Guo H; Du L; Yang B; Yin X; Sun Y
Food Funct; 2018 Jan; 9(1):389-396. PubMed ID: 29215110
[TBL] [Abstract][Full Text] [Related]
34. Quinomycin A reduces cyst progression in polycystic kidney disease.
Radadiya PS; Thornton MM; Daniel EA; Idowu JY; Wang W; Magenheimer B; Subramaniam D; Tran PV; Calvet JP; Wallace DP; Sharma M
FASEB J; 2021 May; 35(5):e21533. PubMed ID: 33826787
[TBL] [Abstract][Full Text] [Related]
35. Myocardin-Related Transcription Factor Mediates Epithelial Fibrogenesis in Polycystic Kidney Disease.
Lichner Z; Ding M; Khare T; Dan Q; Benitez R; Praszner M; Song X; Saleeb R; Hinz B; Pei Y; Szászi K; Kapus A
Cells; 2024 Jun; 13(11):. PubMed ID: 38891116
[TBL] [Abstract][Full Text] [Related]
36. Prothymosin alpha as a cystogen.
Gattone VH
Kidney Int; 2005 May; 67(5):2063-4. PubMed ID: 15840058
[No Abstract] [Full Text] [Related]
37. Renal expression of FGF23 and peripheral resistance to elevated FGF23 in rodent models of polycystic kidney disease.
Spichtig D; Zhang H; Mohebbi N; Pavik I; Petzold K; Stange G; Saleh L; Edenhofer I; Segerer S; Biber J; Jaeger P; Serra AL; Wagner CA
Kidney Int; 2014 Jun; 85(6):1340-50. PubMed ID: 24402093
[TBL] [Abstract][Full Text] [Related]
38. c-Myc is a regulator of the PKD1 gene and PC1-induced pathogenesis.
Parrot C; Kurbegovic A; Yao G; Couillard M; Côté O; Trudel M
Hum Mol Genet; 2019 Mar; 28(5):751-763. PubMed ID: 30388220
[TBL] [Abstract][Full Text] [Related]
39. Effect of prothymosin α on neuroplasticity following cerebral ischemia‑reperfusion injury.
Lee AC; Tai SH; Chen YY; Huang SY; Wu CL; Lee EJ
Mol Med Rep; 2024 Apr; 29(4):. PubMed ID: 38391118
[TBL] [Abstract][Full Text] [Related]
40. L-type calcium channel modulates cystic kidney phenotype.
Jin X; Muntean BS; Aal-Aaboda MS; Duan Q; Zhou J; Nauli SM
Biochim Biophys Acta; 2014 Sep; 1842(9):1518-26. PubMed ID: 24925129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
